Could moringa leaf powder help pregnant women with anemia?

NCT ID NCT06875947

Disease control Sponsor: Universitas Padjadjaran Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding Moringa leaf powder to standard iron pills can better improve hemoglobin levels in pregnant women with iron deficiency anemia. About 59 women in their third trimester will take either Moringa capsules plus iron or iron alone for 60 days. Researchers will measure blood counts, iron markers, and inflammation to see if the natural supplement offers extra benefits.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance: Moringa oleifera leaf micronized powder (dietary supplement) plus standard iron tablets
What this could lead to: If it works, this could provide a natural, affordable supplement to help pregnant women with iron deficiency anemia improve their blood counts and reduce inflammation.
What could go wrong: This is a small, early-stage trial with only 59 participants, so results may not apply widely. Moringa supplements are not a proven replacement for standard iron therapy, and side effects or lack of benefit are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

59 people

The number who actually took part.

Started

May 2025

Expected to finish

May 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 44 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria 1. Demographic Characteristics: * Women aged 18-44 years * Married, have a husband and/or family * Have an ID card 2. Clinical Characteristics: * Pregnant with a gestational age of 28 to \<32 weeks * Live single fetus * Hemoglobin (Hb) 7 - \< 11 g/dl * No congenital abnormalities * No complication (DM, infection, genetic disease) based on history taking, clinical signs and symptoms and treatment history. * Parity \< 4 3. Geographical/Administrative Characteristics: * The study subjects (pregnant women) were located in the working area of the health facility where the study was conducted. Health Facility where the study was conducted. \- Come to the health facility independently or by referral. Exclusion Criteria: * Pregnant women with high risk who dropped out or could not be followed up and pregnant women who gave birth prematurely. * Allergy to Moringa Oleifera leaf micronized powders

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cytokines (il-1, il-6) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Inflammation inflammatory disease iron deficiency anemia Pregnancy Complications, Hematologic pregnancy disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cytokines (il-1, il-6) Hepcidin Inflammation Iron deficiency anemia of pregnancy Moringa oleifera Pregnancy complications

Could moringa leaf powder help pregnant women with anemia?

What the study statuses mean